Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
AIDS Drug Assistance Program
100%
Epidemiologic
100%
Program Features
100%
Structural Features
31%
HIV-infected Patients
31%
Selected States
21%
Health Outcomes
21%
Highly Active Antiretroviral Therapy (HAART)
21%
Virological Response
21%
ART Initiation
21%
Clinical Outcomes
12%
United States
12%
Drug Formulary
10%
Underinsured
10%
Opioid Addiction
10%
Low-income
10%
Quality Care
10%
State-based
10%
Addiction Treatment
10%
Individual-level Factors
10%
Drug Safety
10%
Hepatitis C Virus Infection
10%
Potential Confounders
10%
Cost Containment
10%
Comorbidity
10%
Safety Net
10%
North America
10%
Opportunistic Infection Prophylaxis
10%
Treatment Initiation
10%
Drug Users
10%
Modeling Strategy
10%
Program Policies
10%
Subgroup Analysis
10%
Calendar Time
10%
Prophylaxis Treatment
10%
Antiretroviral Therapy
10%
Clinical Practice Guidelines
10%
State-to-state
10%
Multilevel Modeling
10%
Instrumental Variable Method
10%
Program Services
10%
Medical Necessity
10%
HIV Infection
6%
Persons with HIV
6%
Social Sciences
Assistance Program
100%
AIDS
100%
USA
100%
Human Immunodeficiency Virus
54%
Infectious Disease
25%
Health Outcomes
19%
Client Program
11%
Comorbidity
9%
Hepatitis
9%
Cost Containment
9%
Instrumental Variable
9%
Low Income
9%
Nursing and Health Professions
Acquired Immune Deficiency Syndrome
100%
Human Immunodeficiency Virus
47%
Highly Active Antiretroviral Therapy
38%
Health Outcomes
19%
Client
11%
Clinical Outcome
11%
Drug Safety
9%
Drug Formulary
9%
Opportunistic Infection
9%
Infection Prevention
9%
Cost Control
9%
Clinical Guideline
9%
Multilevel Analysis
9%
Instrumental Variable Analysis
9%
Drug Use
9%
Hepatitis C
9%
Opiate Addiction
9%
Antiviral Therapy
9%
Comorbidity
9%
Human Immunodeficiency Virus Infection
6%